Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1704 of 6351
-
Could a simple nerve block ease menstrual migraines?
Symptom relief Completed: The primary objective of this prospective, randomized, double-blind, placebo-controlled clinical trial is to evaluate whether repetitive bilateral greater occipital nerve (GON) blockade administered with a local anesthetic (0.5% bupivacaine) significantly reduces headache sever…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Cannabis oil shows promise for fibromyalgia sufferers
Symptom relief OngoingRecently, medical cannabis has been shown to be effective in chronic pain conditions such as osteoarthritis, neuropathic pain, and other chronic non-cancer pain. A study showed that fibromyalgia patients who use cannabis report significant improvement in pain symptoms and qualit…
Sponsor: Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Lab-Grown tumor avatars could pick the right cancer drug for each patient
Knowledge-focused Recruiting nowPrecision oncology aims to improve clinical outcome of patients by offering personalized treatment through identifying druggable genomic aberrations within their tumors. This is particularly valid when it comes to offering alternative treatment options for patients with advanced …
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Faith-Based program aims to prevent blindness in black americans at high risk for glaucoma
Prevention Recruiting nowThe purpose of this research is to evaluate if intervention and education can change the behavior of someone's willingness to see an eye care provider to prevent blindness and glaucoma. The researchers are investigating if adding additional resources improves participant access t…
Sponsor: University of Michigan • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
New pill could ease diabetic nerve pain in landmark trial
Symptom relief Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability of VX-993 in participants with pain associated with Diabetic Peripheral Neuropathy (DPN)
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New Triple-Action antibody takes on Hard-to-Treat cancers
Disease control Recruiting nowThis is a first-in-human (FIH), Phase 1a/1b, open-label, multicenter, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-T187 alone and in combination with other therapeu…
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Magic mushroom compound tested for hard-to-treat mental health struggles
Symptom relief Recruiting nowThe primary objective of this study is to investigate the safety, feasibility, and tolerability of psilocybin treatment in individuals with functional impairment due to psychiatric symptoms. The secondary objective of this study is to determine whether individuals with functional…
Phase 1 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Hypnosis app aims to tame hot flashes for breast cancer patients
Symptom relief Recruiting nowPatients treated for breast cancer with hormone therapy (HT) suffer from hot flashes. This side effect impacts treatment adherence. Indeed, approximately 50% of women take less than 80% of the prescribed dose, and up to 50% abandon their treatment before the fifth year of prescri…
Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Engineered immune cells take on liver cancer in early trial
Disease control Recruiting nowThis is a single arm, open-label, dose escalation clinical study to evaluate the safety and efficacy of HRYZ-T102 TCR-T Cell in patients with AFP positive advanced hepatocellular carcinoma and other solid tumors refractory to prior systematic treatments.
Phase 1 • Sponsor: Shanghai Ruiliyuan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could magnetic pulses boost memory in Alzheimer's? new pilot study aims to find out
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if using large-coil (or "deep") repetitive transcranial magnetic stimulation (rTMS) targeting the precuneus and surrounding areas is feasible, tolerable, and potentially efficacious for memory in Alzheimer's Disease. Previous work study…
Phase 1/2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Hair loss pill for women? new trial tests oral minoxidil
Disease control Recruiting nowThe goal of this clinical trial is to learn about oral minoxidil 1mg in the treatment of women with androgenetic alopecia, a type of hormone-imbalanced hair loss. The main questions to answer are to know about that minoxidil 1mg is as effective as minoxidil 2% topical solution (…
Phase 3 • Sponsor: Industrial Farmacéutica Cantabria, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Dancing away Parkinson's symptoms: tango therapy put to the test
Symptom relief CompletedThe purpose of this clinical research is to evaluate the effectiveness of a structured Tango-based (Riabilitango®) therapy compared to a conventional Motor Reconditioning program and a Control group in individuals diagnosed with Parkinson's Disease. The study assesses changes in …
Sponsor: University of Foggia • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Could a nitric oxide mist fight tough lung infections?
Disease control OngoingA Phase 1/2a, Multi-Centre, Randomised, Open-label study to assess the safety, tolerability, PK, and efficacy of RESP30X in Adult NCFB participants with confirmed high-titre respiratory PPMs.
Phase 1/2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New blood test uses AI and lasers to spot High-Risk breast cancer
Diagnosis Recruiting nowEXoPERT has developed a liquid biopsy-based in vitro diagnostic medical device that can diagnose cancer through blood. The in vitro diagnostic medical device for this clinical performance trial is a test device that applies a technology that measures Raman spectroscopic signals o…
Sponsor: EXoPERT • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Alzheimer's polypill shows promise in early trial
Disease control CompletedThis is an estimation-focused Phase 2 study designed to explore and quantify treatment-related changes across multiple clinical outcomes in patients with Alzheimer's disease over a 210-day period. The anticipated study population are males and females aged 50-85 years with very m…
Phase 2 • Sponsor: Noah Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a ketamine mist lift severe depression fast?
Symptom relief Recruiting nowThis is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
Phase 3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Promising drug for kids with rare muscle disease moves to next phase
Disease control Recruiting nowThe purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).
Phase 2/3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New test could spot tumours that dodge radiotherapy
Knowledge-focused Recruiting nowApproximately 50% of cancer patients with solid tumours will be treated with radiotherapy. A significant proportion (\>25%) of patients have hypoxic tumours which respond poorly to radiotherapy. Hypoxic tumours have a poor prognosis. This can be improved with treatment intensific…
Sponsor: University of Manchester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
App-Based therapy aims to slow down paranoia in psychosis
Symptom relief Recruiting nowWorries about harm from others (also known as paranoia) are common. Thinking fast or going on gut feelings is natural but can fuel these worries. For some, fast thinking and worries start to get in the way of life. Cognitive behaviour therapy for psychosis (CBTp) is the recommend…
Sponsor: King's College London • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New drug shows promise for swallowing disorder
Disease control OngoingPhase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solrikitug in adult participants with eosinophilic esophagitis.
Phase 2 • Sponsor: Uniquity One (UNI) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC